Maternal Thyroid Function in Early Pregnancy and Their Relationship With Gestational Diabetes Mellitus
NCT ID: NCT02555332
Last Updated: 2015-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
7729 participants
OBSERVATIONAL
2012-12-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Establish of Specific Reference Ranges for Thyroid Tests in Pregnant Women
NCT02966405
Gestational Age Specific Thyroid Function Reference Range
NCT03663517
Screening of Subclinical Hypothyroidism in Pregnant Women
NCT05801822
Thyroid Stimulating Hormone (TSH) Level Variations in Early Pregnancy
NCT04565873
Normal Range of TSH and FT4 in Pregnancy
NCT04860622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women underwent screening for thyroid function
All these women underwent screening for thyroid function (TSH,FT4,TPOAb) at the first antenatal visit and the 75g oral glucose tolerance test (OGTT) at 24-28 weeks of gestation. The correlation between the combination of TSH level and TPOAb status and the risk of Gestational Diabetes Mellitus was analyzed.
75g oral glucose tolerance test (OGTT)
All these women underwent the 75g oral glucose tolerance test (OGTT) at 24-28 weeks of gestation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
75g oral glucose tolerance test (OGTT)
All these women underwent the 75g oral glucose tolerance test (OGTT) at 24-28 weeks of gestation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. singleton pregnancy;
3. FT4 level is within the normal range;
4. TSH level is normal or beyond the normal range.
Exclusion Criteria
2. thyroid disease history before pregnancy, e.g. hyperthyroidism, clinical hypothyroidism and malignant tumors of the thyroid, regardless of medication treatment is needed or not;
3. twin or multiple gestations;
4. diagnosed with diabetes mellitus before pregnancy, or fasting blood-glucose level ≥ 7.0 mmol/L or HbA1C≥6.5% at the first antenatal visit;
5. diseases causing abnormal glycometabolism or severe co-morbidities or diseases causing abnormal glycometabolism.
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai First Maternity and Infant Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hao Ying
Director,Clinical research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hao Ying, PHD
Role: PRINCIPAL_INVESTIGATOR
Shanghai First Maternity and Infant Hospital
References
Explore related publications, articles, or registry entries linked to this study.
Agarwal MM, Dhatt GS, Punnose J, Bishawi B, Zayed R. Thyroid function abnormalities and antithyroid antibody prevalence in pregnant women at high risk for gestational diabetes mellitus. Gynecol Endocrinol. 2006 May;22(5):261-6. doi: 10.1080/09513590600630470.
Pascual Corrales E, Andrada P, Auba M, Ruiz Zambrana A, Guillen Grima F, Salvador J, Escalada J, Galofre JC. Is autoimmune thyroid dysfunction a risk factor for gestational diabetes? Endocrinol Nutr. 2014 Aug-Sep;61(7):377-81. doi: 10.1016/j.endonu.2014.01.009. Epub 2014 Mar 26. English, Spanish.
Tudela CM, Casey BM, McIntire DD, Cunningham FG. Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstet Gynecol. 2012 May;119(5):983-8. doi: 10.1097/AOG.0b013e318250aeeb.
Olivieri A, Valensise H, Magnani F, Medda E, De Angelis S, D'Archivio M, Sorcini M, Carta S, Baccarini S, Romanini C. High frequency of antithyroid autoantibodies in pregnant women at increased risk of gestational diabetes mellitus. Eur J Endocrinol. 2000 Dec;143(6):741-7. doi: 10.1530/eje.0.1430741.
Karakosta P, Alegakis D, Georgiou V, Roumeliotaki T, Fthenou E, Vassilaki M, Boumpas D, Castanas E, Kogevinas M, Chatzi L. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab. 2012 Dec;97(12):4464-72. doi: 10.1210/jc.2012-2540. Epub 2012 Sep 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REB#12-054
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.